Craig P A, Olson S T, Shore J D
Division of Biochemical Research, Henry Ford Hospital, Detroit, Michigan 48202.
J Biol Chem. 1989 Apr 5;264(10):5452-61.
The kinetics of alpha-factor Xa inhibition by antithrombin III (AT) were studied in the absence and presence of heparin (H) with high affinity for antithrombin by stopped-flow fluorometry at I 0.3, pH 7.4 and 25 degrees C, using the fluorescence probe p-aminobenzamidine (P) and intrinsic protein fluorescence to monitor the reactions. Active site binding of p-aminobenzamidine to factor Xa was characterized by a 200-fold enhancement and 4-nm blue shift of the probe fluorescence emission spectrum (lambda max 372 nm), 29-nm red shift of the excitation spectrum (lambda max 322 nm), and dissociation constant (KD) of about 80 microM. Under pseudo-first order conditions [( AT]0, [H]0, [P]0 much greater than [Xa]0), the observed factor Xa inactivation rate constant (kobs) measured by p-aminobenzamidine displacement or residual enzymatic activity increased linearly with the "effective" antithrombin concentration (i.e. corrected for probe competition) up to 300 microM in the absence of heparin, indicating a simple bimolecular process with a rate constant of 2.1 x 10(3) M-1 s-1. In the presence of heparin, a similar linear dependence of kobs on effective AT.H complex concentration was found up to 25 microM whether the reaction was followed by probe displacement or the quenching of AT.H complex protein fluorescence due to heparin dissociation, consistent with a bimolecular reaction between AT.H complex and free factor Xa with a 300-fold enhanced rate constant of 7 x 10(5) M-1 s-1. Above 25 microM AT.H complex, an increasing dead time displacement of p-aminobenzamidine and a downward deviation of kobs from the initial linear dependence on AT.H complex concentration were found, reflecting the saturation of an intermediate Xa.AT.H complex with a KD of 200 microM and a limiting rate of Xa-AT product complex formation of 140 s-1. Kinetic studies at catalytic heparin concentrations yielded a kcat/Km for factor Xa at saturating antithrombin of 7 x 10(5) M-1 s-1 in agreement with the bimolecular rate constant obtained in single heparin turnover experiments. These results demonstrate that 1) the accelerating effect of heparin on the AT/Xa reaction is at least partly due to heparin promoting the ordered assembly of antithrombin and factor Xa in an intermediate ternary complex and that 2) heparin catalytic turnover is limited by the rate of conversion of the ternary complex intermediate to the product Xa-AT complex with heparin dissociation occurring either concomitant with this step or in a subsequent faster step.
在不存在和存在对抗凝血酶具有高亲和力的肝素(H)的情况下,于离子强度0.3、pH 7.4和25℃条件下,采用停流荧光法,使用荧光探针对氨基苯甲脒(P)和蛋白质固有荧光来监测反应,研究了抗凝血酶III(AT)对α-因子Xa的抑制动力学。对氨基苯甲脒与因子Xa的活性位点结合表现为探针荧光发射光谱(λmax 372 nm)增强200倍且蓝移4 nm、激发光谱(λmax 322 nm)红移29 nm,解离常数(KD)约为80 μM。在准一级条件下[(AT)0、(H)0、(P)0远大于(Xa)0],通过对氨基苯甲脒置换或残余酶活性测定的观察到的因子Xa失活速率常数(kobs)在不存在肝素时,随“有效”抗凝血酶浓度(即针对探针竞争进行校正)线性增加,直至300 μM,表明这是一个简单的双分子过程,速率常数为2.1×10³ M⁻¹ s⁻¹。在存在肝素的情况下,无论反应是通过探针置换监测还是由于肝素解离导致的AT·H复合物蛋白质荧光猝灭来跟踪,kobs对有效AT·H复合物浓度都有类似的线性依赖性,直至25 μM,这与AT·H复合物和游离因子Xa之间的双分子反应一致,速率常数提高300倍,为7×10⁵ M⁻¹ s⁻¹。在25 μM以上的AT·H复合物浓度时,观察到对氨基苯甲脒的死时间位移增加,且kobs偏离对AT·H复合物浓度的初始线性依赖性向下,这反映了KD为200 μM的中间Xa·AT·H复合物的饱和以及Xa - AT产物复合物形成的极限速率为140 s⁻¹。在催化肝素浓度下的动力学研究得出,在抗凝血酶饱和时因子Xa的kcat/Km为7×10⁵ M⁻¹ s⁻¹,与单肝素周转实验中获得的双分子速率常数一致。这些结果表明:1)肝素对AT/Xa反应的加速作用至少部分归因于肝素促进抗凝血酶和因子Xa在中间三元复合物中的有序组装;2)肝素的催化周转受三元复合物中间体向产物Xa - AT复合物转化速率的限制,肝素解离要么与此步骤同时发生,要么在随后更快的步骤中发生。